- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.02. | Brain+ A/S: Update on in-court restructuring proceedings - 4 February 2026 | 185 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT No. 2026-5
BRAIN+ A/S - Investor News
Copenhagen, Denmark, 4 February 2026, Brain+ A/S (Nasdaq First North: BRAINP)
Copenhagen, Denmark, 4 February 2026 Brain+ A/S (the "Company")... ► Artikel lesen | |
| BRAIN+ A/S Aktie jetzt für 0€ handeln | |||||
| 20.01. | Brain+ A/S: Notice of in-court restructuring proceedings of BRAIN+ A/S | 114 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT No. 2026-2
Brain+ A/S - Inside information
Copenhagen, Denmark, 20 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)
Copenhagen, Denmark, 20 January 2026 - BRAIN+ A/S (the "Company")... ► Artikel lesen | |
| 20.01. | Brain+ A/S: Brain+ is seeking restructuring proceedings | 194 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT NO. 2026-1
Copenhagen, Denmark, 20 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)
As previously announced on 19 November 2025, Brain+ A/S has been exploring various options... ► Artikel lesen | |
| 08.01. | Brain+ A/S: Brain+ Investor Update - December 2025 | 115 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 8 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S reports continued international expansion alongside strengthened traction in its home market of Denmark... ► Artikel lesen | |
| 04.12.25 | Brain+ A/S: Brain+ Investor Update - November | 147 | GlobeNewswire (Europe) | NEWS RELEASE
Brain+ Investor Update - November
Copenhagen, Denmark, 4 December 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S reports continued commercial traction, national research recognition... ► Artikel lesen | |
| 19.11.25 | Brain+ A/S: Brain+ A/S updates its financial guidance for 2025 | 179 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT No. 2025-19
Copenhagen, Denmark, 19 November 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") updates its financial guidance for 2025 to reflect... ► Artikel lesen | |
| 06.11.25 | Brain+ A/S: Brain+ investor update - October | 152 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 6 November 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S reports continued commercial traction and operational expansion in its October investor update,... ► Artikel lesen | |
| 06.10.25 | Brain+ A/S: Brain+ appoints new Chief Financial Officer | 161 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-18Copenhagen, Denmark, 6 October 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has appointed Otto Rasmussen, an experienced financial... ► Artikel lesen | |
| 24.09.25 | Brain+ A/S: Brain+ launches first Ayla NHS pilot with one of the UK's largest primary care practices | 165 | GlobeNewswire (Europe) | NEWS RELEASECopenhagen, Denmark, 24 September 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has signed an agreement with a large primary care practice in the South... ► Artikel lesen | |
| 16.09.25 | Brain+ A/S: Brain+ signs agreement with Agincare Homes - the fourth UK care home group to deploy effective dementia therapy with Ayla | 263 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, September 16, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has signed an agreement with Agincare Homes Holdings Ltd, UK ("Agincare")... ► Artikel lesen | |
| 15.09.25 | Brain+ A/S: The Chief Financial Officer to transition, replacement search has been initiated | 183 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-17
Copenhagen, Denmark, September 15, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") announces that its Chief Financial Officer... ► Artikel lesen | |
| 02.09.25 | Brain+ A/S: Brain+ expands its agreement with Southcare Homes Group to deploy Ayla across the group | 307 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 2 September 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has signed an expanded contract with Southcare Homes Group ("Southcare")... ► Artikel lesen | |
| 28.08.25 | Brain+ A/S: Brain+ publishes Half Year Report for 2025 | 270 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-16Copenhagen, Denmark, August 28, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
In H1 2025, Brain+ A/S ("Brain+" or "the Company") realized a net result of DKK -8.0... ► Artikel lesen | |
| 05.06.25 | Brain+ A/S: Brain+ signs agreement with UK care home group Majesticare deploying Ayla for effective dementia care | 178 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 5 June 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has signed a partnership with Majesticare, a leading UK care home provider... ► Artikel lesen | |
| 30.05.25 | Brain+ A/S: Brain+ A/S - Minutes of Annual General Meeting | 170 | GlobeNewswire (Europe) | Copenhagen, Denmark, 30 May 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Today at 08:00 CEST, the Annual General Meeting was held in Brain+ A/S, ("Brain+" or "the Company"). A total of 16.45 % of... ► Artikel lesen | |
| 05.05.25 | Brain+ A/S: Brain+ selected for the NHS Dementia Innovators Programme in the UK | 317 | GlobeNewswire (Europe) | Copenhagen, Denmark, 5 May 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has been selected for the Dementia Innovators Programme in the United Kingdom (UK),... ► Artikel lesen | |
| 16.04.25 | Brain+ A/S: Brain+ appoints CCO Devika Wood as new CEO | 423 | GlobeNewswire (Europe) | Copenhagen, Denmark, 16 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S ("Brain+" or the "Company") announces that the Board has appointed the Company's Chief Commercial Officer (CCO)... ► Artikel lesen | |
| 02.04.25 | Brain+ A/S: Brain+ announces outcome of unit rights issue | 332 | GlobeNewswire (Europe) | Copenhagen, Denmark, 2 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA... ► Artikel lesen | |
| 19.03.25 | Brain+ A/S: Brain+ expands its UK sales pipeline to €+500,000 in revenue and reveals Key Performance Indicators | 240 | GlobeNewswire (Europe) | Copenhagen, Denmark, 19 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") today reports continued strong momentum in its sales pipeline, now exceeding €500... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,820 | +0,45 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Fresenius von 60 auf 57 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Die Aktien der Bad Homburger hätten nach dem... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,780 | -0,64 % | Siemens Healthineers: Drei Belastungen | Am 7. Mai wird Siemens Healthineers Zahlen zum zweiten Quartal publizieren. Die Analysten der DZ Bank glauben, dass diese schwach ausfallen werden. Drei Aspekte belasten derzeit die Daten: Die US-Zölle... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,780 | +0,03 % | Shortseller-Positionen aktuell: Brenntag, pbb, FMC, Ionos, Renk, Suss MicroTec, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ADAPTHEALTH | 10,595 | +8,67 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline | ||
| CARL ZEISS MEDITEC | 23,620 | +0,08 % | Shortseller-Positionen aktuell: Carl Zeiss Meditec, Gerresheimer, GFT, Lanxess, Renk, Puma, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| GERRESHEIMER | 17,670 | -4,33 % | Aktien KW 10 - Trump zerbombt Märkte. Cuba next? Völkerrecht - nicht für USA? News. Rheinmetall. Hensoldt. Renk. Gerresheimer. Nakiki. GFT Technologies. Verbio. Lufthansa. 3U Holding. Palfinger. HometoGo. Mutares. Nordex. Ernst Russ. Sixt | Aktien: Letzte Woche, freitags abends machten wir uns Gedanken über einen anstehenden Aktienmonat März - mit neuen Kursausschlägen nach oben. Wir erwähnten zwar die "bekannten Baustellen und Problemfelder(n)... ► Artikel lesen | |
| DRAEGERWERK | 86,50 | +1,76 % | DRAEGERWERK AG & CO KGAA ST zeigt strukturelle Schwäche | ||
| FIREFLY NEUROSCIENCE | 2,740 | +63,58 % | Firefly Neuroscience, Inc.: Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD | Over 22 million Americans are diagnosed with ADHD - yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive1 Firefly's AI-powered EEG/ERP... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,350 | -0,72 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HIMS & HERS HEALTH | 21,540 | +0,28 % | Hims & Hers Aktie springt 40% nach möglicher Partnerschaft mit Novo Nordisk | Novo Nordisk und Hims & Hers wollen ihren Streit um Abnehmmedikamente offenbar beilegen und könnten mit einer neuen GLP-1-Partnerschaft den Markt aufmischen. Der dänische Pharmakonzern Novo Nordisk... ► Artikel lesen | |
| OTTOBOCK | 53,30 | -0,37 % | Aktien KW 9 - Stehen Ostergeschenke für Aktionäre im März an? Trotz Zöllen, Trump, Krisen, KI-Zweifeln? News. Rheinmetall. Ottobock. Hensoldt. Renk. TKMS. STEYR. Forvia Hella. DEFAMA. Hochtief. Shelly Group. Aixtron. Hamborner REIT. Hensoldt. SFC Energy | Aktien: Diese Woche ist bei Einzelwerten einiges passiert, der Gesamtmarkt bleibt auf hohem Niveau, Branchenrotation in Richtung "sicherer" Wetten, Aktien im KI-Schatten bleiben unter Druck und nach... ► Artikel lesen | |
| UNITEDHEALTH | 246,95 | +0,16 % | Dividendenbekanntmachungen (09.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANSIX INC US00773T1016 0,16 USD 0,1377 EUR ALLISON TRANSMISSION HOLDINGS INC US01973R1014 0,29 USD 0,2496 EUR ALPHABET INC CDR CA02080K1049 0... ► Artikel lesen | |
| ESSILORLUXOTTICA | 206,40 | +0,29 % | EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 11, 2026 | ||
| PROGYNY | 17,510 | +0,11 % | Progyny, Inc. - 8-K, Current Report | ||
| ECKERT & ZIEGLER | 14,750 | -0,67 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen |
BRAIN+ A/S gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRAIN+ A/S finden Sie auf Wallstreet Online.